Vitrolife AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Vitrolife AB
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient’s fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
/ 
Frequently asked questions
To buy Vitrolife AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vitrolife AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vitrolife AB is VITR:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vitrolife AB has its primary listing on NASDAQ OMX Stockholm. You can trade Vitrolife AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vitrolife AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Vitrolife AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Vitrolife AB.